Beth Dobbin, who competed for Great Britain at the Tokyo Olympics in 2021, has been diagnosed with myalgic encephalomyelitis (ME) and is now largely bedbound for as much as 22 hours a day.
The former Olympic sprinter’s condition has drastically reduced her ability to train and take part in competitions. Five years after representing her country at the Games, Dobbin’s diagnosis marks a profound change in the day-to-day life of an elite athlete.
ME, also known as myalgic encephalomyelitis, is a chronic and often severely disabling illness. There is currently no cure, and the diagnosis typically involves long-term management rather than a definitive treatment.
Dobbin’s situation underscores the unpredictable trajectories athletes can face when struck by chronic health problems. Her experience highlights broader questions about long-term support for elite competitors who develop serious medical conditions during or after their sporting careers.